|
See related Exforge[易安穩] information |
|
|
|
製造商 |
Novartis |
|
代理/經銷商 |
Novartis |
|
成份 |
Per 5/80 mg tab Amlodipine besylate 5 mg, valsartan 80 mg. Per 5/160 mg tab Amlodipine besylate 5 mg, valsartan 160 mg |
|
適應症 |
Treatment of HTN. Not indicated for the initial therapy of HTN. |
|
用量 |
1 tab daily. |
|
用法 |
May be taken with or without food |
|
美國食品藥物管理局之懷孕等級 |
Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective). |
|
禁忌 |
Pregnancy (2nd & 3rd trimesters). |
|
注意事項 |
Risk of hypotension in patients with an activated renin-angiotensin system eg, vol- &/or salt-depleted patients receiving high doses of diuretics. Heart failure or recent MI & in patients undergoing surgery or dialysis. Severe aortic stenosis. Severe hepatic impairment, biliary obstructive disorders. Severe heart failure whose renal function depended on the activity of renin-angiotensin system. Renal impairment. β-blockers withdrawal should be gradual. |
|
不良反應 |
Peripheral edema, vertigo. Nasopharygnitis, upper respiratory tract infections, dizziness.
View ADR Monitoring Website[參閱藥物不良反應監測表格] |
|
交互作用 |
K-sparing diuretics, K supplements, K-containing salt substitutes.
View more drug interactions with Exforge[易安穩] |
|
本商品之市售規格 |
|
劑型 |
包裝 |
圖片 |
|
Exforge 5/80 mg 膜衣錠 |
|
Exforge 28's |
 |
|
|
Exforge 5/160 mg 膜衣錠 |
|
|
|
Manufacturer: |
Novartis |
|
Distributor: |
Novartis |
|
 |
|
|
|
